| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c2e77f8dfda692ca527454d23ecc03 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate |
2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c95d86ad41424f245114ecba4e20647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f33bfa2dc3d565cbc59156c480c8cd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e15b8efd864cc912f9a4506a078c7b1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1100d8be87cee021df02e246f0565810
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6eab3811130f0878fcd6629a6d2b6e7 |
| publicationDate |
2021-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021113462-A1 |
| titleOfInvention |
Compositions and methods for treating pulmonary edema or lung inflammation |
| abstract |
A pharmaceutical composition for administering directly to the pulmonary tract of a subject includes a salt of triiodothyronine and a pharmaceutically acceptable buffer, adjusted to pH of 5.5-8.5. The composition can be administered prophylactically or therapeutically to a subject to treat lung inflammation or pulmonary edema. |
| priorityDate |
2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |